Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Lyfnua
Lyfnua
departments:
呼吸科
drug:
片剂
Active:
Gefapixant
indication:
Lyfnua是一种用于治疗成人慢性(长期)咳嗽的药物,这种咳嗽无法解释或其他治疗方法无效。
Licensor:
Merck Sharp & Dohme B.V.
Approved Country/Region:
欧盟
Approval time:
2023-09-15